25 May Biosynth Carbosynth Acquires Aalto Bio Reagents
BroadOak Partners advised Aalto Bio Reagents on the sale of the company to Biosynth Carbosynth, a KKR and Ampersand portfolio company. The full press release is below. Addition of Aalto Bio Reagents expands Biosynth Carbosynth’s offer to its clinical diagnostics customers. Staad, 25 May 2022 - Biosynth Carbosynth...
Stay connected
Partner with BroadOak